Cellular Biomedicine - 48 Year Dividend History | CBMG

Historical dividend payout and yield for Cellular Biomedicine (CBMG) since 1971. The current TTM dividend payout for Cellular Biomedicine (CBMG) as of April 18, 2019 is $0.00. The current dividend yield for Cellular Biomedicine as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.312B $0.000B
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13